ISOPSA SUBSTANTIALLY REDUCES UNNEEDED BIOPSIES IN A REAL-WORLD OFFICE SETTING
Daniel Hettel, Aimee Kestranek, Robert Rochelle, Mark Stovsky,Eric Klein,*, Cleveland, OHhttps://www.auajournals.org/doi/abs/10.1097/JU.0000000000001972.20INTRODUCTION AND OBJECTIVE: We assessed the clinicalutility of IsoPSA a novel test to assess the risk of high-grade prostatecancer e to determine its effect on reducing unneeded prostate biopsies in a real-world setting.METHODS: 636 patients were enrolled by 58 providers practicing across a range of […]